Viewing Study NCT05642195


Ignite Creation Date: 2025-12-24 @ 1:31 PM
Ignite Modification Date: 2026-02-26 @ 7:24 PM
Study NCT ID: NCT05642195
Status: SUSPENDED
Last Update Posted: 2025-12-24
First Post: 2022-12-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module